Diabetic Retinopathy Market is expected to touch $8.52 Billion by 2021 | Market Data Forecast
Diabetic Retinopathy Market by Type of Treatment (Anti-Vascular Endothelial Growth Factor (VEGF) drug, Intraocular Steroid Injection, Laser Surgery and Vitrectomy)
(EMAILWIRE.COM, March 28, 2018 ) Global Diabetic Retinopathy Market has been estimated at USD 6.1 billion in 2016 and is projected to reach USD 8.52 billion by 2021, at a CAGR of 6.9% during the forecast period from 2016 to 2021. Diabetes is a long-lasting disorder associated with defects in the secretion of insulin from the pancreas or hyperglycaemia associated to insulin resistance which eventually leads to long term multi-organ complications of nerves, eye, blood vessels, kidneys, and heart.
The most common and severe sight threatening complication of diabetes is Diabetic Retinopathy (DR) which leads to damaging of the blood vessels present in the retina of the eye. The treatment procedure of diabetic retinopathy depends on the various stages of diabetic retinopathy. It is one of the most dominant reasons of blindness in adults globally.
Get a comprehensive overview of the Market: https://www.marketdataforecast.com/market-reports/global-diabetic-retinopathy-market-936/
The growing incidence of diabetes coupled with increasing prevalence of blindness due to diabetes is expected to drive market growth over the forecast period. Increasing global geriatric population prevalence and strong awareness for early detection of diabetic retinopathy will be essential factors for driving global diabetic retinopathy market demand. However, dearth of skilled ophthalmologist combined with poor primary infrastructure is expected to restrain the market growth.
The global Diabetic Retinopathy Market has been segmented on the basis of indication into Non-Proliferative Diabetic Retinopathy (NPDR) and Proliferative Diabetic Retinopathy (PDR). NPDR is further sub segmented as Mild, Moderate and Severe. Based on Treatment type the market is bifurcated into Anti-Vascular Endothelial Growth Factor (VEGF) drug, Intraocular Steroid Injection, Laser Surgery and Vitrectomy. By end users division is among Hospitals, Ophthalmic Clinics and Ambulatory Surgical Centers. Non-proliferative retinopathy dominated the overall market size estimated to lead the market. Augmented incidence of diabetes, lack of diagnosis at right time, and non-compliant retinal screening of diabetic patients are expected to boost the growth of non-proliferative diabetic retinopathy market share.
Request for Sample Brochure: https://www.marketdataforecast.com/market-reports/global-diabetic-retinopathy-market-936/request-sample
Based on geography, the market has been segmented into North America, Europe, Asia-Pacific, Latin America and Middle-East and Africa. North America dominated the market followed by Asia-Pacific and Europe. The factors attributable for North America are having high obesity rates while Europe has large population of baby boomers. The emerging nations of Asia Pacific such as China and India are anticipated to witness significant growth during the forecast period owing to expanding geriatric population base, increasing disposable income, innovation in diagnostics, rising research funding for diabetes and a large pool of patients.
The Major companies in Diabetic Retinopathy treatment market are Bayer AG, Pfizer Inc., Hoffmann-La Roche ltd, Regeneron Pharmaceutical Inc., Novartis AG, Valeant Pharmaceutical International Inc., Abbott Laboratories Inc., Alimera Science Inc. and Ampio Pharmaceuticals Inc.
scope of the report provides:
The evaluation of the current market for your product or services and the future implications of the market
Addresses the opportunities by better understanding the market through size estimates and growth rate analysis to forecast the market for the future
Extensive segmentation to understand the dynamics of market at a very granular level by splitting down the market to the smallest segment
Addresses the key market dynamics involving the drivers, restraints and challenges with an aim of providing insights for gaining market share
The factors responsible for the shaping of the industry as it is as a result of competitive environment is analyzed through Porters Five Forces
The effects of political, economic, social, technological, legal and environmental factors on the industry is analyzed through PESTLE analysis to better understand the aspects of strategic management required to comply with the exogenous and endogenous factors
Strategic evaluation of the key players to gain insights of their performance allowing access to their product portfolio, financial performance and the strengths of their business strategic developments
Comparative study of the firms across the industry measuring their performances based on market share and recent activities in order to achieve competitive intelligence
Equip you with the information providing with the investment opportunities in the industry
Looking for more? If you are in need of a specific research study, we have an expertise in undertaking a customized study and will aid to meet your research requirement to the fullest.
About Us:
Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, we cater to the needs of both individual and corporate clients. Our analyst team comprises expert professionals in market research, who with their collective knowledge and sksillset dedicatedly serve clients from various industries and regions.
The most common and severe sight threatening complication of diabetes is Diabetic Retinopathy (DR) which leads to damaging of the blood vessels present in the retina of the eye. The treatment procedure of diabetic retinopathy depends on the various stages of diabetic retinopathy. It is one of the most dominant reasons of blindness in adults globally.
Get a comprehensive overview of the Market: https://www.marketdataforecast.com/market-reports/global-diabetic-retinopathy-market-936/
The growing incidence of diabetes coupled with increasing prevalence of blindness due to diabetes is expected to drive market growth over the forecast period. Increasing global geriatric population prevalence and strong awareness for early detection of diabetic retinopathy will be essential factors for driving global diabetic retinopathy market demand. However, dearth of skilled ophthalmologist combined with poor primary infrastructure is expected to restrain the market growth.
The global Diabetic Retinopathy Market has been segmented on the basis of indication into Non-Proliferative Diabetic Retinopathy (NPDR) and Proliferative Diabetic Retinopathy (PDR). NPDR is further sub segmented as Mild, Moderate and Severe. Based on Treatment type the market is bifurcated into Anti-Vascular Endothelial Growth Factor (VEGF) drug, Intraocular Steroid Injection, Laser Surgery and Vitrectomy. By end users division is among Hospitals, Ophthalmic Clinics and Ambulatory Surgical Centers. Non-proliferative retinopathy dominated the overall market size estimated to lead the market. Augmented incidence of diabetes, lack of diagnosis at right time, and non-compliant retinal screening of diabetic patients are expected to boost the growth of non-proliferative diabetic retinopathy market share.
Request for Sample Brochure: https://www.marketdataforecast.com/market-reports/global-diabetic-retinopathy-market-936/request-sample
Based on geography, the market has been segmented into North America, Europe, Asia-Pacific, Latin America and Middle-East and Africa. North America dominated the market followed by Asia-Pacific and Europe. The factors attributable for North America are having high obesity rates while Europe has large population of baby boomers. The emerging nations of Asia Pacific such as China and India are anticipated to witness significant growth during the forecast period owing to expanding geriatric population base, increasing disposable income, innovation in diagnostics, rising research funding for diabetes and a large pool of patients.
The Major companies in Diabetic Retinopathy treatment market are Bayer AG, Pfizer Inc., Hoffmann-La Roche ltd, Regeneron Pharmaceutical Inc., Novartis AG, Valeant Pharmaceutical International Inc., Abbott Laboratories Inc., Alimera Science Inc. and Ampio Pharmaceuticals Inc.
scope of the report provides:
The evaluation of the current market for your product or services and the future implications of the market
Addresses the opportunities by better understanding the market through size estimates and growth rate analysis to forecast the market for the future
Extensive segmentation to understand the dynamics of market at a very granular level by splitting down the market to the smallest segment
Addresses the key market dynamics involving the drivers, restraints and challenges with an aim of providing insights for gaining market share
The factors responsible for the shaping of the industry as it is as a result of competitive environment is analyzed through Porters Five Forces
The effects of political, economic, social, technological, legal and environmental factors on the industry is analyzed through PESTLE analysis to better understand the aspects of strategic management required to comply with the exogenous and endogenous factors
Strategic evaluation of the key players to gain insights of their performance allowing access to their product portfolio, financial performance and the strengths of their business strategic developments
Comparative study of the firms across the industry measuring their performances based on market share and recent activities in order to achieve competitive intelligence
Equip you with the information providing with the investment opportunities in the industry
Looking for more? If you are in need of a specific research study, we have an expertise in undertaking a customized study and will aid to meet your research requirement to the fullest.
About Us:
Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, we cater to the needs of both individual and corporate clients. Our analyst team comprises expert professionals in market research, who with their collective knowledge and sksillset dedicatedly serve clients from various industries and regions.
Contact Information:
Market Data Forecast.
Abhishek Shukla
Tel: +1-888-702-9626
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
Market Data Forecast.
Abhishek Shukla
Tel: +1-888-702-9626
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results